Read + Share

Amedeo Smart

Independent Medical Education


Read + Share

Hayakawa M, Nakajima H, Harano K, Watanabe S, et al. Impact of platinum-free interval and bevacizumab on second-line chemotherapy following progression on first-line PARP inhibitor maintenance in advanced ovarian cancer: A retrospective cohort study. Gynecol Oncol 2025;204:70-78.
PMID: 41275790


Privacy Policy